Jarrett, W. F. H., B. W. Oneil, J. M. Gaukroger, K. T. Smith, H. M. Laird, and M. S. Campo. 1990. Studies on vaccination against papillomaviruses—the immunity after infection and vaccination with bovine papillomaviruses of different types. Veterinary Record 126(19):473-475.

Kang, L. W., N. Crawford, M. L. K. Tang, J. Buttery, J. Royle, M. Gold, C. Ziegler, P. Quinn, S. Elia, and S. Choo. 2008. Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: Retrospective cohort study. British Medical Journal 337(7683):1392-1396.

Manhart, L. E., K. K. Holmes, L. A. Koutsky, T. R. Wood, D. L. Kenney, Q. H. Feng, and N. B. Kiviat. 2006. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sexually Transmitted Diseases 33(8):502-508.

Marrazzo, J. M., K. Stine, and L. A. Koutsky. 2000. Genital human papillomavirus infection in women who have sex with women: A review. American Journal of Obstetrics and Gynecology 183(3):770-774.

Mendoza Plasencia, Z., M. Gonzalez Lopez, M. L. Fernandez Sanfiel, and J. R. Muniz Montes. 2010. Acute disseminated encephalomyelitis with tumefactive lesions after vaccination against human papillomavirus [in Spanish]. Neurologia 25(1):58-59.

Molano, M., A. van den Brule, M. Plummer, E. Weiderpass, H. Posso, A. Arslan, C. Meijer, N. Munoz, S. Franceschi, and H. P. V. S. Grp. 2003. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: A population-based, 5-year follow-up study. American Journal of Epidemiology 158(5):486-494.

Rivera Medina, D. M., A. Valencia, A. de Velasquez, L. M. Huang, R. Prymula, J. Garcia-Sicilia, L. Rombo, M. P. P. David, D. Descamps, K. Hardt, and G. Dubin. 2010. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: A randomized, controlled trial in adolescent girls. Journal of Adolescent Health 46(5):414-421.

Schaffer, V., S. Wimmer, I. Rotaru, R. Topakian, H. P. Haring, and F. T. Aichner. 2008. HPV vaccine: A cornerstone of female health a possible cause of ADEM? Journal of Neurology 255(11):1818-1820.

Schiller, J. T., and D. R. Lowy. 1996. Papillomavirus-like particles and HPV vaccine development. Seminars in Cancer Biology 7(6):373-382.

Schiller, J. T., I. H. Frazer, and D. R. Lowry. 2008. Chapter 14. Human papillomavirus vaccines. In Vaccines, edited by S. A. Plotkin, W. A. Orenstein, and P. A. Offit. Philadelphia, PA: Saunders/Elsevier. Pp. 244-257.

Slade, B. A., L. Leidel, C. Vellozzi, E. J. Woo, W. Hua, A. Sutherland, H. S. Izurieta, R. Ball, N. Miller, M. M. Braun, L. E. Markowitz, and J. Iskander. 2009. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. Journal of the American Medical Association 302(7):750-757.

Souayah, N., P. A. Michas-Martin, A. Nasar, N. Krivitskaya, H. A. Yacoub, H. Khan, and A. I. Qureshi. 2010. Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine 29(5):886-889.

Sutton, I., R. Lahoria, I. Tan, P. Clouston, and M. Barnett. 2009. CNS demyelination and quadrivalent HPV vaccination. Multiple Sclerosis 15(1):116-119.

Trottier, H., and E. L. Franco. 2006. The epidemiology of genital human papillomavirus infection. Vaccine 24S1:S1/4-S1/15.

Verstraeten, T., D. Descamps, M. P. David, T. Zahaf, K. Hardt, P. Izurieta, G. Dubin, and T. Breuer. 2008. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 26(51):6630-6638.

Weinstock, H., S. Berman, and W. Cates. 2004. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health 36(1):6-10.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement